RMD Stock Analysis: Buy, Sell, or Hold?
RMD - ResMed Inc.
$258.31
0.70 (0.27%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Jan 29, 2026
0d
Get Alerted When RMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: RMD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$380.72
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$236.39
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RMD is currently trading at $258.31, which is considered extended relative to its 30-day fair value range of $245.50 to $257.67. The stock's valuation (Forward PE: 21.4) is in line with its historical norms (22.4). Remarkably, the market is currently pricing in an annual earnings decline of 1.6% over the next few years. This pessimistic expectation contrasts with the company's recent 12.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RMD is in a strong downtrend. The price is approaching resistance at $264.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $292.67 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RMD is in a strong downtrend. The price is approaching resistance at $264.09. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $292.67 (+13.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$245.50 -
$257.67
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding RMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($292.67)
Fair Price Analysis
30-Day Fair Range
$245.50 -
$257.67
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$245.21
Resistance Level
$264.09
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
21.38
Wall Street Target
$292.67
(+13.6%)
Revenue Growth (YoY)
9.1%
Earnings Growth (YoY)
12.3%
Profit Margin
27.4%
Valuation Discount vs History
-1.6% cheaper
PE vs Historical
21.4 vs 22.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.6%
(market-implied from PE analysis)
1-Year Target
$253.49
(-2%)
2-Year Target
$249.43
(-3%)
3-Year Target
$245.44
(-5%)
3-Yr Target (if PE normalizes)
(PE: 21→22)
$257.10
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 10.3%)
$360.82
(+40%)
Base:
(SPY PE: 21.4, Growth: 10.3%)
$346.01
(+34%)
Bear:
(PE: 18.2, Growth: 10.3%)
$294.11
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 26.18 | Current EPS (TTM): $9.76
Bull Case
$346.89
(+35%)
Analyst growth 23.4%, PE expands to 28.8
Base Case
$315.36
(+22%)
Market implied 23.4%, PE stable at 26.2
Bear Case
$173.74
(-33%)
Severe decline -20.0%, PE contracts to 22.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.4 to 22.4
Stabilization Target:
$269.84
(+4.7%)
PE Expansion Potential:
+4.7%
Last updated: January 30, 2026 5:54 PM ET
Data refreshes hourly during market hours. Next update: 6:54 PM
Data refreshes hourly during market hours. Next update: 6:54 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael J Farrell
SELL
8009 shares
2025-10-07
Michael J Rider
SELL
100 shares
2025-10-01
John Hernandez
SELL
2575 shares
2025-08-18
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 58 HOLD |
Advanced RMD Option Strategies
Professional options setups generated by AI based on today's RMD price and gamma walls.
